Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-26 @ 12:52 AM
NCT ID:
NCT01848834
Group ID:
EG004
Title:
Cohort B2: Head & Neck Cancer Expansion
Description:
Participants received pembrolizumab, 200 mg, IV once every 3 weeks, and continued to receive study drug until disease progression, death, withdrawal of consent, Investigator decision, or end of study (up to 2 years). Participants who stopped study treatment without progression (e.g. completed 2 years) may have been eligible for up to 1 year of retreatment upon subsequently experiencing disease progression.
Deaths Number Affected:
110
Deaths Number At Risk:
None
Serious Number Affected:
60
Serious Number At Risk:
132
Other Number Affected:
124
Other Number At Risk:
132
Study:
NCT01848834
Results Section:
NCT01848834
Adverse Events Module:
NCT01848834